Development of novel method of non-viral efficient gene transfer into neonatal cardiac myocytes

Journal of Molecular and Cellular Cardiology

Volumn 39, Issue 3, 2005, Pages 503-509

  Tashiro, Hironori ^a,b   Aoki, Motokuni ^a   Isobe, Mitsuaki ^b   Hashiya, Naotaka ^a   Makino, Hirofumi ^a   Kaneda, Yasufumi ^a   Ogihara, Toshio ^a   Morishita, Ryuichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

Cardiac myocyte; Gene therapy; Gene transfer; HVJ envelope; Sendai virus

Indexed keywords

FLUORESCEIN ISOTHIOCYANATE; LUCIFERASE; OLIGODEOXYNUCLEOTIDE; PROTAMINE SULFATE;

ANIMAL CELL; ARTICLE; CARDIOVASCULAR DISEASE; CONCENTRATION RESPONSE; CYTOTOXICITY; ENZYME ACTIVITY; FLUORESCENCE; GENE TARGETING; GENE THERAPY; GENE TRANSFER; GENE VECTOR; GENETIC TRANSFECTION; GENOME; HEART MUSCLE CELL; NEWBORN; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PLASMID; PRIORITY JOURNAL; PROTEIN TARGETING; RAT; SENDAI VIRUS; VIRUS ENVELOPE;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCENT DYES; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HEART VENTRICLES; INJECTIONS; LIPOSOMES; LUCIFERASES; MYOCARDIUM; MYOCYTES, CARDIAC; OLIGONUCLEOTIDES; PLASMIDS; PROTAMINES; RATS; RATS, SPRAGUE-DAWLEY; SENDAI VIRUS; TRANSFECTION; VIRAL ENVELOPE PROTEINS;

SENDAI VIRUS;

EID: 23644459325     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2005.06.007     Document Type: Article

References (37)

1. A.C. Nathwani, R. Benjamin, A.W. Nienhuis, and A.M. Davidoff Current status and prospects for gene therapy Vox Sang. 87 2004 73 81
2. T.A. Raitko, J.P. Cummings, J. Blebea, and K.A. Matuszewski Clinical gene therapy for nonmalignant disease Am. J. Med. 115 2003 560 569
3. I. Baumgartner, A. Pieczek, O. Manor, R. Blair, M. Kearney, and K. Walsh Constitutive expression of phVEGF 165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia Circulation 97 1998 1114 1123
4. J.M. Isner, I. Baumgartner, G. Rauh, R. Schainfeld, R. Blair, and O. Manor Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results J. Vasc. Surg. 28 1998 964 973
5. K. Makinen, H. Manninen, M. Hedman, P. Matsi, H. Mussalo, and E. Alhava Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: randomized, placebo-controlled, double-blinded phaseIIstudy Mol. Ther. 6 2002 127 133
6. A.J. Comerota, R.C. Throm, K.A. Miller, T. Henry, N. Chronos, and J. Laird Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: preliminary results of a phase I trial J. Vasc. Surg. 35 2002 930 936
7. D.W. Losordo, P.R. Vale, J.F. Symes, C.H. Dunnington, D.D. Esakof, and M. Maysky Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia Circulation 98 1998 2800 2804
8. P.R. Vale, D.W. Losordo, C.E. Milliken, M. Maysky, D.D. Esakof, and J.F. Symes Left ventricular electromechanical mapping to assess efficacy of phVEGF165 gene transfer for therapeutic angiogenesis in chronic myocardial ischemia Circulation 102 2000 965 974
9. M. Laitinen, J. Hartikainen, M.O. Hiltunen, J. Eranen, M. Kiviniemi, and O. Narvanen Catheter-mediated vascular endothelial growth factor gene transfer to human coronary arteries after angioplasty Hum. Gene Ther. 11 2000 263 270
10. M.J. Kutryk, D.P. Foley, M. van den Brand, J.N. Hamburger, W.J. van der Giessen, and P.J. deFeyter Local intracoronary administration of antisense oligonucleotide against c-myc for the prevention of in-stent restenosis: results of the randomized investigation by the Thoraxcenter of antisense DNA using local delivery and IVUS after coronary stenting (ITALICS) trial J. Am. Coll. Cardiol. 39 2002 281 287
11. M.J. Mann, A.D. Whittemore, M.C. Donaldson, M. Belkin, M.S. Conte, and J.F. Polak Ex-vivo gene therapy of human vascular bypass grafts with E2F decoy: the PREVENT single-center, randomized, controlled trial Lancet 354 1999 1493 1498
12. R.J. Guzman, P. Lemarchand, R.G. Crystal, S.E. Epstein, and T. Finkel Efficient gene transfer into myocardium by direct injection of adenovirus vectors Circ. Res. 73 1993 1202 1207
13. E.A. Kass, P.E. Falck, M. Alvira, J. Rivera, P.M. Buttrick, and B.A. Wittenberg Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo Proc. Natl. Acad. Sci. USA 90 1993 11498 11502
14. L.A. Kirshenbaum, W.R. MacLellan, W. Mazur, B.A. French, and M.D. Schneider Highly efficient gene transfer into adult ventricular myocytes by recombinant adenovirus J. Clin. Invest. 92 1993 381 387
15. K.E. Ellison, N.H. Bishopric, K.A. Webster, R. Morishita, G.H. Gibbons, and Y. Kaneda Fusigenic liposome-mediated DNA transfer into cardiac myocytes J. Mol. Cell. Cardiol. 28 1996 1385 1399
16. R.S. Coffin, M.K. Howard, D.V. Cumming, C.M. Dollery, J. MacEwan, and D.M. Yellon Gene delivery to the heart in vivo and to cardiac myocytes and vascular smooth muscle cells in vitro using herpes virus vectors Gene Ther. 3 1996 560 566
17. S. Gojo, S. Kitamura, W.T. Germeraad, Y. Yoshida, K. Niwaya, and K. Kawachi Ex vivo gene transfer into myocardium using replication-defective retrovirus Cell Transplant. 5 1996 S81 S84
18. M. Aoki, R. Morishita, A. Muraishi, A. Moriguchi, T. Sugimoto, and K. Maeda Efficient in vivo gene transfer into the heart in the rat myocardial infarction model using the HVJ (hemagglutinating virus of Japan)-liposome method J. Mol. Cell. Cardiol. 29 1997 949 959
19. A.J.M. Roks, Y.M. Pinto, M. Paul, F. Pries, M. Stula, and T. Eschenhagen Vectors based on Semliki Forest virus for rapid and efficient gene transfer into non-endothelial cardiovascular cells: comparison to adenovirus Cardiovasc. Res. 35 1997 498 504
20. Y. Maeda, U. Ikeda, M. Shimpo, S. Ueno, Y. Ogasawara, and M. Urabe Efficient gene transfer into cardiac myocytes using adeno-associated virus (AAV) vectors J. Mol. Cell. Cardiol. 30 1998 1341 1348
21. J. Zhao, G.J. Pettigrew, J. Thomas, J.I. Vandenberg, L. Delriviere, and E.M. Bolton Lentiviral vectors for delivery of genes into neonatal and adult ventricular cardiac myocytes in vitro and in vivo Basic Res. Cardiol. 97 2002 348 358
22. Y. Kaneda, K. Iwaki, and T. Uchida Increased expression of DNA cointroduced with nuclear protein in adult rat liver Science 243 1989 375 378
23. K. Kato, M. Nakanishi, Y. Kaneda, T. Uchida, and Y. Okada Expression of hepatitis B virus surface antigen in adult rat liver J. Biol. Chem. 266 1991 3361 3364
24. Y. Kaneda, T. Nakajima, T. Nishikawa, S. Yamamoto, H. Ikegami, and N. Suzuki Hemagglutinating virus of Japan (HVJ) envelope vector as a versatile gene delivery system Mol. Ther. 6 2002 219 226
25. Y. Kaneda Virus (Sendai virus envelopes) mediated gene transfer J.E. Celis Cell biology: a laboratory handbook, vol. 3 1994 Academic Press Orlando, FL 50 57
26. S. Li, and L. Huang In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Ther. 4 1997 891 900
27. R. Morishita Perspective in progress of cardiovascular gene therapy J. Pharmacol. Sci. 95 2004 1 8
28. S.L. Jacobson, and H.M. Piper Cell cultures of adult cardiomyocytes as models of the myocardium J. Mol. Cell. Cardiol. 18 1986 661 678
29. V.J. Dzau, R. Morishita, and G.H. Gibbons Gene therapy in the cardiovascular diseases Trends Biotechnol. 11 1993 205 210
30. M. Brenner Gene transfer by adenovectors Blood 94 1999 3965 3967
31. P. Sinnaeve, O. Varenne, D. Collen, and S. Janssens Gene therapy in the cardiovascular system: update Cardiovasc. Res. 44 1999 498 506
32. Y. Kaneda, Y. Saeki, and R. Morishita Gene therapy using HVJ-liposomes: the best of both worlds? Mol. Med. Today 5 1999 298 303
33. K. Cornetta, and W.F. Anderson Protamine sulfate as an effective alternative to polybrene in retroviral-mediated gene transfer: implications for human gene therapy J. Virol. Methods 23 1989 187 194
34. P.R. Clark, A.T. Stopeck, J.L. Brailey, Q. Wang, J. McArthur, and M.H. Finer Polycations and cationic lipids enhance adenovirus transduction and transgene expression in tumor cells Cancer Gene Ther. 6 1999 437 446
35. M. Lanuti, C. Kouri, S.D. Force, M.Y. Chang, K. Amin, and K. Xu Use of protamine to augment adenovirus-mediated cancer gene therapy Gene Ther. 6 1999 1600 1610
36. Y.W. Yang, and Y.C. Hsieh Protamine sulfate enhances the transduction efficiency of recombinant adeno-associated virus-mediated gene delivery Pharm. Res. 18 2001 922 927
37. F.L. Sorgi, S. Bhattacharya, and L. Huang Protamine sulfate enhances lipid-mediated gene transfer Gene Ther. 4 1997 961 968